Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while h

Genomics and synthetic biology are transforming healthcare through precision medicine and gene editi

Illumina raises its 2026 guidance as strong clinical sequencing demand and NovaSeq X adoption fuel g

Evercore ISI Group analyst Vijay Kumar maintains Illumina (NASDAQ:ILMN) with a Outperform and low

U.S. futures fell as Pinterest missed Q3 estimates and cut guidance; Intel, ATEC, Reddit, Roblox and

Although the revenue and EPS for Illumina (ILMN) give a sense of how its business performed in the q

Illumina, Inc. (ILMN) Q3 2026 Earnings Call Transcript

Illumina (ILMN) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Est

Illumina NASDAQ: ILMN reported third-quarter results above its prior guidance, citing strong clinica

Illumina (NASDAQ:ILMN) reported third-quarter financial results on Thursday. The transcript from the

Illumina (NASDAQ:ILMN) reported third-quarter financial results on Thursday. The transcript from the

Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 16.1% to $0.92 during Thursday's after-m

Illumina (NASDAQ:ILMN) raises FY2026 Adj EPS guidance from $5.30-$5.40 to $5.40-$5.45 vs $5.36 analy

Illumina (NASDAQ:ILMN) reported quarterly earnings of $1.44 per share which beat the analyst consens

SAN DIEGO, Oct. 29, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company")

The Fund declined 4.75% while the Russell 2500 Index declined 6.37%. Key contributors include Illumi

Amazon headlines Thursday’s reports, with investors focused on whether accelerating AWS growth and h

Evaluate the expected performance of Illumina (ILMN) for the quarter ended September 2026, looking b

Microsoft Corporation was the portfolio's top contributor during the quarter. Suncor Energy outperfo

SAN DIEGO, Oct. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members

FBT has outperformed RSPH by a wide margin recently. The question is whether you want to own the fun

Moderna's stock has taken a big hit that could signal the end of this year's cancer vaccine-driven r

Atlatl Advisers LLC acquired a new stake in shares of Illumina, Inc. (NASDAQ: ILMN) in the third qua

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 4.59% on an annualized

Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings bea

Illumina (ILMN) is rated a Buy, driven by robust demand for consumables and NovaSeq X instruments, s

Illumina's Q3 results may benefit from strong clinical demand, NovaSeq X adoption, instrument placem

SpaceX's blowout third quarter and Super Micro's guidance hike revive the AI trade, lifting

DRAGEN Ultra, BioInsight Platform Workflow Orchestrator, and BioInsight Platform Learning Cohorts ar

SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members

Rate and energy headlines have kept the broad market jumpy, yet one sector keeps finding buyers. Hea

Canaccord Genuity analyst Kyle Mikson maintains Illumina (NASDAQ:ILMN) with a Hold and raises the

First Citizens Bank and Trust Co. purchased a new position in Illumina, Inc. (NASDAQ: ILMN) during t

Illumina (NASDAQ:ILMN) has outperformed the market over the past 15 years by 3.81% on an annualized

TD Cowen analyst Dan Brennan maintains Illumina (NASDAQ:ILMN) with a Hold and raises the price ta

Barclays analyst Luke Sergott maintains Illumina (NASDAQ:ILMN) with a Underweight and raises the

RBC Capital analyst Dan Leonard maintains Illumina (NASDAQ:ILMN) with a Outperform and raises the

Guggenheim analyst Subbu Nambi maintains Illumina (NASDAQ:ILMN) with a Buy and raises the price t

Leerink Partners analyst Puneet Souda maintains Illumina (NASDAQ:ILMN) with a Outperform and rais

Piper Sandler analyst David Westenberg maintains Illumina (NASDAQ:ILMN) with a Overweight and rai

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 5.48% on an annualized

On Thursday, Illumina (NASDAQ:ILMN) discussed second-quarter financial results during its earnings c

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 4.87% on an annualized

U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent

The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi p

Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising

Analysts upgraded SFNC, OBIO, and more.

Analysts upgraded Sagimet, Figure, Illumina, Martin Marietta and Waters, raising price targets and i

UBS analyst Doug Schenkel upgrades Illumina (NASDAQ:ILMN) from Neutral to Buy and raises the pric

https://www.spglobal.com/spdji/en//documents/indexnews/announcements/20260904-1484999/1484999_shuffl